Overview

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Status:
RECRUITING
Trial end date:
2026-11-19
Target enrollment:
Participant gender:
Summary
A Phase I modular study to assess the effect of oral saruparib on other treatments in patients with advanced solid malignancies.
Phase:
PHASE1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Parexel
Treatments:
ATP Binding Cassette Transporter, Subfamily B, Member 1
Digoxin
Furosemide
Metformin
Rabeprazole
Rosuvastatin Calcium